Cargando…
849. Reduced CIED Infections with an Antibacterial Envelope: Microbiologic Analysis of the WRAP-IT Study
BACKGROUND: Cardiovascular implantable electronic device (CIED) infections are associated with significant morbidity, mortality, and cost. There is limited evidence on antibiotic prophylactic strategies to prevent CIED infection. Recently, the TYRX Envelope, which elutes a combination of rifampin an...
Autores principales: | Sohail, Muhammad R, Corey, G Ralph, Wilkoff, Bruce L, Poole, Jeanne, Mittal, Suneet, Kennergren, Charles, Greenspon, Arnold J, Cheng, Alan, Lande, Jeff, Lexcen, Daniel R, Tarakji, Khaldoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809461/ http://dx.doi.org/10.1093/ofid/ofz359.034 |
Ejemplares similares
-
Risk factors for hematoma in patients undergoing cardiac device procedures: A WRAP-IT trial analysis
por: Tarakji, Khaldoun G., et al.
Publicado: (2022) -
Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial
por: Wilkoff, Bruce L., et al.
Publicado: (2020) -
Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial
por: Wilkoff, Bruce L., et al.
Publicado: (2020) -
Antibiotic eluting envelopes: evidence, technology, and defining high-risk populations
por: Callahan, Thomas D, et al.
Publicado: (2021) -
Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX™ antibacterial envelope
por: Boriani, Giuseppe, et al.
Publicado: (2021)